0
Zynerba Pharmaceuticals, Inc. Banner Image

Zynerba Pharmaceuticals, Inc.

  • Ticker ZYNE
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Zynerba Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Devon, Pennsylvania
Zynerba (NASDAQ: ZYNE) is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal delivery. Cannabinoids interact with specific receptors throughout the body toMore produce pharmacologic effects, primarily in the CNS and immune systems.
REPORT RATINGS
4.8 / 5.0 (169)

Zynerba Pharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 169 reviews.

Zynerba Pharmaceuticals, Inc.

Most Recent Annual Report

Zynerba Pharmaceuticals, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Zynerba Pharmaceuticals, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!